169 related articles for article (PubMed ID: 24673383)
1. Skin tumors with matrical differentiation: lessons from hair keratins, beta-catenin and PHLDA-1 expression.
Battistella M; Carlson JA; Osio A; Langbein L; Cribier B
J Cutan Pathol; 2014 May; 41(5):427-36. PubMed ID: 24673383
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
[TBL] [Abstract][Full Text] [Related]
3. On the regulation of hair keratin expression: lessons from studies in pilomatricomas.
Cribier B; Peltre B; Grosshans E; Langbein L; Schweizer J
J Invest Dermatol; 2004 May; 122(5):1078-83. PubMed ID: 15140206
[TBL] [Abstract][Full Text] [Related]
4. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
[TBL] [Abstract][Full Text] [Related]
5. Panfollicular carcinoma or trichoblastic carcinoma with panfollicular differentiation?
Fedeles F; Cha J; Chaump M; Theroux B; Farrell D; Dufresne R; Robinson-Bostom L
J Cutan Pathol; 2013 Nov; 40(11):976-81. PubMed ID: 24320809
[TBL] [Abstract][Full Text] [Related]
6. Basal Cell Carcinoma With Matrical Differentiation: Clinicopathologic, Immunohistochemical, and Molecular Biological Study of 22 Cases.
Kyrpychova L; Carr RA; Martinek P; Vanecek T; Perret R; Chottová-Dvořáková M; Zamecnik M; Hadravsky L; Michal M; Kazakov DV
Am J Surg Pathol; 2017 Jun; 41(6):738-749. PubMed ID: 28368926
[TBL] [Abstract][Full Text] [Related]
7. β-catenin in canine skin: immunohistochemical pattern of expression in normal skin and cutaneous epithelial tumours.
Bongiovanni L; Malatesta D; Brachelente C; D'Egidio S; Della Salda L
J Comp Pathol; 2011; 145(2-3):138-47. PubMed ID: 21388636
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1-dependent induction and nuclear translocation of FHL2 promotes keratin expression in pilomatricoma.
Friedrichs J; Fink D; Mauch C; Kindler D; Hartmann W; Schüle R; Buettner R; Friedrichs N
Virchows Arch; 2015 Feb; 466(2):199-208. PubMed ID: 25477051
[TBL] [Abstract][Full Text] [Related]
9. Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature.
Ali F; Brown A; Gottwald L; Thomas J
J Cutan Pathol; 2005 Jul; 32(6):445-8. PubMed ID: 15953381
[TBL] [Abstract][Full Text] [Related]
10. Follicular germinative cells in pilomatricoma.
Nishie W; Kimura T
Am J Dermatopathol; 2006 Dec; 28(6):510-3. PubMed ID: 17122495
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma with matrical differentiation: expression of beta-catenin [corrected] and osteopontin.
Del Sordo R; Cavaliere A; Sidoni A
Am J Dermatopathol; 2007 Oct; 29(5):470-4. PubMed ID: 17890917
[TBL] [Abstract][Full Text] [Related]
12. Where pigmented pilomatricoma and melanocytic matricoma collide.
Tallon B; Cerroni L
Am J Dermatopathol; 2010 Dec; 32(8):769-73. PubMed ID: 20881831
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin.
Haskell HD; Haynes HA; McKee PH; Redston M; Granter SR; Lazar AJ
J Cutan Pathol; 2005 Mar; 32(3):245-50. PubMed ID: 15701088
[TBL] [Abstract][Full Text] [Related]
14. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
Sellheyer K; Nelson P
J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin expression in benign and malignant pilomatrix neoplasms.
Hassanein AM; Glanz SM
Br J Dermatol; 2004 Mar; 150(3):511-6. PubMed ID: 15030335
[TBL] [Abstract][Full Text] [Related]
16. Mutations in exon 3 of the CTNNB1 gene (beta-catenin gene) in cutaneous adnexal tumors.
Kazakov DV; Sima R; Vanecek T; Kutzner H; Palmedo G; Kacerovska D; Grossmann P; Michal M
Am J Dermatopathol; 2009 May; 31(3):248-55. PubMed ID: 19384065
[TBL] [Abstract][Full Text] [Related]
17. Basaloid tumors in nevus sebaceus revisited: the follicular stem cell marker PHLDA1 (TDAG51) indicates that most are basal cell carcinomas and not trichoblastomas.
Sellheyer K; Cribier B; Nelson P; Kutzner H; Rütten A
J Cutan Pathol; 2013 May; 40(5):455-62. PubMed ID: 23489134
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
Demirkan NC; Bir F; Erdem O; Düzcan E
J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
[TBL] [Abstract][Full Text] [Related]
19. PHLDA1, a follicular stem cell marker, differentiates clear-cell/granular-cell trichoblastoma and clear-cell/granular cell basal cell carcinoma: a case-control study, with first description of granular-cell trichoblastoma.
Battistella M; Peltre B; Cribier B
Am J Dermatopathol; 2014 Aug; 36(8):643-50. PubMed ID: 23719479
[TBL] [Abstract][Full Text] [Related]
20. Matrical Carcinoma With Melanocytic Proliferation and Prominent Squamoid Whorls.
Villada G; Romagosa R; Miteva M; Romanelli P
Am J Dermatopathol; 2016 Jan; 38(1):e11-4. PubMed ID: 26275314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
